Fluorescein angiography is a valuable diagnostic tool, but it’s not without its limitations. It’s invasive, for some patients it can cause a severe allergic reaction, and a recent shortage of fluorescein may make it necessary to limit the use of this imaging technology and potentially seek a surrogate marker of inflammation. Artificial intelligence (AI) just may help clinicians accomplish that, according to S. Saeed Mohammadi, MD, FICO, who presented a paper on the topic at the American Academy of Ophthalmology (AAO) 2024 meeting, held in Chicago from October 18 to October 21, 2024. #AAO2024 Read more: https://bit.ly/3AZfDmU #FluoresceinAngiography #AllergicReaction #Inflammation #Uveitis #AI #MedTech #FundusPhotography #NoninfectiousUveitis #Ophthalmology #EyeCare
